基于国际经验探究中国保健食品原料管理研究

田明; 孙璐; 李昱霏; 胡昊; 冯军

doi:10.13386/j.issn1002-0306.2021030064

基于国际经验探究中国保健食品原料管理研究

doi: 10.13386/j.issn1002-0306.2021030064

田明^1,,
孙璐¹,
李昱霏¹,
胡昊²,
冯军^1, ,

1.
国家市场监督管理总局发展研究中心，北京 100088
2.
华中农业大学，湖北武汉 430070

基金项目: 国家项目重点研发计划“食品安全突发事件及重大事件应急演练及应急保障决策系统研究”（2018YFC1603700）。

详细信息

作者简介:
田明（1986−），男，博士，副研究员，研究方向：食品安全监管，E-mail: tianm@samrdrc.org.cn

通讯作者:
冯军（1970−），男，本科，研究方向：食品安全监管，E-mail: fengj@samrdrc.org.cn

中图分类号: TS201.1
计量
- 文章访问数: 203
- HTML全文浏览量: 55
- PDF下载量: 24
- 被引次数: 0
出版历程
- 收稿日期: 2021-03-08
- 网络出版日期: 2021-05-26
- 刊出日期: 2021-07-02

Research on Raw Material Management for Health Food in China Based on International Experience

TIAN Ming^1
,,
SUN Lu¹,
LI Yufei¹,
HU Hao²,
FENG Jun^{1
, ,}

1.
State Administration for Market Regulation Development Research Center, Beijing 100088, China
2.
Huazhong Agricultural University, Wuhan 430070, China

摘要

摘要: 随着人造肉等未来食品的出现，食品可使用的原料将不断增加，保健食品的品类也将不断丰富。保健食品原料管理是保健食品注册与备案工作的重点和难点，管活、管住、管优保健食品原料是保证保健食品安全、有效和质量可控的关键。本文在总结我国保健食品原料分类及使用情况，梳理国内外保健食品原料管理经验的基础上，分析了我国保健食品原料管理存在的问题并提出了相关建议和意见，旨在服务监管部门制定科学合理的监管政策。
- 国际经验 /
- 保健食品 /
- 原料管理 /
- 启示
Abstract: With the emergence of artificial meat and other future foods, the raw materials which can be used in foods will continue to increase, and the categories of health foods will continue to be enriched.The management of raw materials for health food is the key point and difficulty of health food registration and filing. Flexible management, control management, optimized management is the key to ensuring the safety, effectiveness and quality of health food. Based on summarizing the classification and use of health food raw materials in China, and combing the management experience of health food raw materials domestic and foreign, this article analyzes the problems existing in the management of health food raw materials in China and puts forward relevant suggestions and opinions for government, aiming to serve the regulatory authorities to formulate scientifically and reasonably regulatory policies.
- international experience /
- health food /
- raw material management /
- inspiration

HTML全文

参考文献(50)

[1]	田明, 孙璐, 王茜, 等. 新冠肺炎疫情之下保健食品行业消费调查分析及政策建议[J]. 中国食品学报,2020,20(9):356−359.
[2]	国家市场监督管理总局官网. 市场监管总局在京召开保健食品监管工作座谈会 [EB/OL].(2019.7.26)[2021.03.25]. http://www.samr.gov.cn/xw/zj/201907/t20190726_305176.html.
[3]	赵洪静, 宛超, 张李伟, 等. 对我国保健食品管理若干问题的思考[J]. 中国现代中药,2017,19(5):604−609.
[4]	卫生部. 卫生部关于进一步规范保健食品原料管理的通知(卫法监发[2002]51号)[EB/OL]. (2002.03.11)[2021.03.25]. http://www.nhfpc.gov.cn/sps/s3593/200810/bc239ea3d226449b86379f645dfd881d.shtml.
[5]	中央政府网. 关于当归等6种新增按照传统既是食品又是中药材的物质公告(2019年第8号)[EB/OL]. (2019.11.25)[2021.03.25]. http://www.nhc.gov.cn/sps/s7885/202001/b941b6138e93414cb08aed926ca3c631.shtml.
[6]	惠伯棣, 张旭, 宫平. 食品原料在我国功能性食品中的应用研究进展[J]. 食品科学,2016,37(17):296−302. doi: 10.7506/spkx1002-6630-201617049
[7]	兰韬, 吴琦, 赵琳, 等. 保健食品功效成分、功能声称及其检测标准现状研究[J]. 食品工业科技,2021,42(1):387−396.
[8]	李庆, 金润浩, 姜国哲, 等. 2006~2015年我国已注册保健食品现状分析[J]. 食品科学,2017,38(3):292−298.
[9]	田明, 冯军, 宛超, 等. 国外保健食品类似产品原料管理的研究及启示[J]. 中国食品学报,2020,20(10):316−321.
[10]	田明, 冯军, 孙璐, 等. 美国膳食补充剂管理研究及对中国的启示[J/OL]. 中国食物与营养. https: //doi.org/10.19870/j.cnki.11-3716/ts.20201215.004.
[11]	Porter, Donna V. Dietary supplement health and education act of 1994: P. L. 103−417[J]. Nutrition Today,1995.
[12]	杰富礼. 美国保健食品原料及食品原料审批法规介绍[J]. 中国卫生监督杂志,2011,18(1):25−27. doi: 10.3969/j.issn.1007-6131.2011.01.005
[13]	Kuszak A J, Hopp D C, Williamson J S, et al. Approaches by the US National Institutes of Health to support rigorous scientific research on dietary supplements and natural products[J]. Drug Testing & Analysis,2016:413.
[14]	TGA. How we regulate medicines[EB/OL]. (2019-06-20)[2021.03.25]. https://www.tga.gov.au/how-we-regulatemedicines.
[15]	TGA. The three-tiered risk-based framework for complementary medicines[EB/OL]. (2018-03-27)[2021.03.25]. https://www.tga.gov.au/sites/default/files/threetiered-risk-based-framework-factsheet.pdf.
[16]	TGA. Therapeutic goods (permissible ingredients) determination (No.2) 2019[EB/OL]. (2019-09-02)[2021.03.25]. https: //www. legislation. gov. au/Details/F2019C00748.
[17]	TGA. Poisons Standard October 2019[EB/OL]. (2019-09-06)[2021.03.25]. https://www.legislation.gov.au/Details/F2019L01197.
[18]	TGA. Therapeutic goods (permissible indications) determination (No.1) 2019[EB/OL]. (2019-02-28)[2021.03.25]. https://www.legislation.gov.au/Details/F2019L00262.
[19]	Government of Canada. Natural health products ingredients databases[EB/OL]. [2021.03.25]. http://webprod.hc-sc.gc.ca/nhpid-bdipsn/search-rechercheReq.do.
[20]	Government of Canada. Natural health products regulations[EB/OL]. [2004]. http://laws-lois.justice.gc.ca/ eng/regulations/SOR-2003-196/FullText.html.
[21]	Government of Canada. Food and drugs act[EB/OL]. [2021.03.25] http://laws-lois.justice.gc.ca/eng/acts/F-27/.
[22]	Government of Canada. The approach to natural health products[EB/OL]. (2013-12-19)[2021.03.25] http://www.hc-sc.gc.ca/dhp-mps/prodnatur/nhp-new-nouvelle-psn-eng.php.
[23]	Government of Canada. Management of product licence applications for natural health products[EB/OL]. (2014-10-30)[2021.03.25]. http://hc-sc.gc.ca/dhp-mps/prodnatur/legislation/pol/pla-dlmm_manage-gestion-eng.php.
[24]	Government of Canada. Pathway for licensing natural health products making modern health claims V1.0[EB/OL]. (2012-12-27)[2021.03.25]. http://www.hc-sc.gc.ca/dhp-mps/prodnatur/legislation/docs/modern-eng.php.
[25]	Government of Canada. Natural health products ingredients database issue form guide[EB/OL]. (2010-10)[2021.03.25]. http://www.hc-sc.gc.ca/dhp-mps/pubs/natur/issue_form_demande-eng.php.
[26]	Government of Canada. Pathway for licensing natural health products used as traditional medicines[EB/OL]. (2012-12-20)[2021.03.25]. http://www.hc-sc.gc.ca/dhp-mps/prodnatur/legislation/docs/tradit-eng.php.
[27]	Government of Canada. Compendium of monographs V3.0[EB/OL]. (2013-6-13)[2021.03.25]. http://www.hc-sc.gc.ca/dhp-mps/consultation/natur/2013-08-compendium-eng.php.
[28]	Government of Canada. Product licensing guidance document[EB/OL]. (2016-12)[2021.03.25]. http://www.hc-sc.gc.ca/dhp-mps/prodnatur/legislation/docs/license-licence_guide_tc-tm-eng.php.
[29]	田明, 赵静波, 张孜仪. 加拿大天然健康产品管理的模式及启示[J]. 食品工业科技,2019,40(10):355−359, 368.
[30]	田明, 佟娜, 宋涛, 等. 韩国健康功能食品管理研究及对中国的启示[J]. 食品与机械,2018,34(8):211−215.
[31]	秦菲, 陈文, 魏涛, 等. 韩国对功能食品的管理[J]. 食品工业科技,2009,30(11):283−286.
[32]	兰洁, 王瑾, 王森, 等. 国际保健品管理的比较研究(下)[J]. 亚太传统医药,2008,4(8):5−8.
[33]	CCFL. Codex guidelines for use of nutritional and health claims[S]. ALINORM 04/27/41. Codex Committee on Food Labeling, 2004.
[34]	Health functional food code[EB/OL](2011-11-17)[2021.03.25]. http://www.mfds.go.kr/eng/eng/index.do?nMenuCode=120&page=2&mode=view&boardSeq=70011.
[35]	Regulation on approval of functional ingredient for functional food[EB/OL](2007-07-11)[2021.03.25]. http://www.mfds.go.kr/eng/eng/index.do?nMenuCode=120&page=2&mode=view&boardSeq=70014.
[36]	田明, 张孜仪, 赵静波, 等. 日本保健功能食品的管理及对我国的启示[J]. 中国食品卫生杂志,2019,31(3):240−245.
[37]	刘洪宇, 邓少伟, 钮正睿, 等. 日本保健功能食品管理制度及特定保健用食品批准情况概要[J]. 中国药事,2012,26(5):521−525. doi: 10.3969/j.issn.1002-7777.2012.05.030
[38]	刘长喜, 吴坚, 赵彦红, 等. 日本国保健机能食品制度及其对我国的几点启示[J]. 中国食品卫生杂志,2005,17(4):320−325. doi: 10.3969/j.issn.1004-8456.2005.04.009
[39]	张中朋. 日本保健机能食品上市许可制度[J]. 中国现代中药,2014,16(2):164−166.
[40]	日本厚生劳动省. 特定保健用食品的审查等操作及指导要领的修订: 食品安全法案第0201002号[Z/OL]. (2005-02-01)[2021.03.25]. http://www.mhlw.go.jp/topics/bukyoku/iyaku/syoku-anzen/topics/050131/index.html.
[41]	日本厚生劳动省. 营养标示基准: 平成15年厚生劳动省告示第176号[Z/OL]. (2003)[2021.03.25]. http://www.caa.go.jp/foods/index4.html#m02.
[42]	日本厚生劳动省. 無承認無許可医薬品の監視指導について厚生劳动省[Z/OL]. (2015-04-01)[2021.03.25]. https://www.mhlw.go.jp/kinkyu/diet/dl/kanshishidou. pdf.
[43]	田明, 房军. 中国保健食品原料管理基本现状及改进建议[J]. 食品与机械,2019,35(1):12−14, 119.
[44]	张李伟, 赵洪静, 白鸿, 等. 中国保健食品法律法规体系发展与现状研究[J]. 中国食品卫生杂志,2008,20(3):232−235. doi: 10.3969/j.issn.1004-8456.2008.03.011
[45]	单峰, 黄璐琦, 郭娟, 等. 药食同源的历史和发展概况[J]. 生命科学,2015,27(8):1061−1069.
[46]	厉梁秋, 田明. 保健食品类似产品国内外管理情况报告[R]. 北京: 中国医药科技出版社, 2020: 28−29.
[47]	国家市场监督管理总局. 关于发布《保健食品原料目录(一)》和《允许保健食品声称的保健功能目录(一)》的公告[Z/OL]. (2016-12-27)[2021.03.25]. http://www.samr.gov.cn/tssps/tzgg/zjwh/202011/t20201105_323074.html.
[48]	萨翼, 陈广耀, 王进博, 等. 已批准增强免疫力功能的中药类保健食品现状及监管建议[J]. 中国中药杂志,2019,44(5):885−890.
[49]	李婉, 赵海潞. 浅论中医正气理论与现代免疫学的内在联系[C]. 天津: 第十二届全国免疫学学术大会, 2017.
[50]	宁霄, 金绍明, 曹进, 等. 完善监管制度, 强化科技创新“双轨护航”保健食品质量安全[J]. 食品安全质量检测学报,2020,11(23):9001−9008.